-
Signature
-
/s/ Katherine A. Krebel, Attorney-in-Fact
-
Stock symbol
-
DRS
-
Transactions as of
-
Apr 1, 2025
-
Transactions value $
-
-$231,673
-
Form type
-
4
-
Date filed
-
4/3/2025, 04:37 PM
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
transaction |
DRS |
Common Stock |
Options Exercise |
$0 |
+7.25K |
+13.15% |
$0.00 |
62.4K |
Apr 1, 2025 |
Direct |
F1 |
transaction |
DRS |
Common Stock |
Tax liability |
-$115K |
-3.5K |
-5.61% |
$32.87 |
58.9K |
Apr 1, 2025 |
Direct |
F2 |
transaction |
DRS |
Common Stock |
Options Exercise |
$0 |
+4.34K |
+7.36% |
$0.00 |
63.2K |
Apr 1, 2025 |
Direct |
F3 |
transaction |
DRS |
Common Stock |
Tax liability |
-$68.9K |
-2.1K |
-3.31% |
$32.87 |
61.2K |
Apr 1, 2025 |
Direct |
F2 |
transaction |
DRS |
Common Stock |
Sale |
-$47.7K |
-1.5K |
-2.45% |
$31.82 |
59.7K |
Apr 2, 2025 |
Direct |
F4 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
transaction |
DRS |
Restricted Stock Unit |
Options Exercise |
$0 |
-7.25K |
-26.36% |
$0.00 |
20.3K |
Apr 1, 2025 |
Common Stock |
7.25K |
|
Direct |
F1 |
transaction |
DRS |
Restricted Stock Unit |
Options Exercise |
$0 |
-4.34K |
-21.4% |
$0.00 |
15.9K |
Apr 1, 2025 |
Common Stock |
4.34K |
|
Direct |
F3 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: